Prescription Information Modernization Act of 2026

S. 5242, the Prescription Information Modernization Act of 2026, would let drug and biologic manufacturers provide FDA-required prescribing information electronically instead of automatically including paper copies. Prescribers and dispensers would still have the right to opt in to continue receiving paper information, or to request paper copies as needed at no additional cost. The Department of Health and Human Services would be required to issue implementing regulations, designed to minimize adverse economic impacts on prescribers and dispensers, within one year of enactment, and to hold a public workshop with stakeholders within two years to discuss further improving the format and usability of prescribing information.

The bill primarily affects drug and biological product manufacturers, and the health care professionals (prescribers and dispensers) who currently receive paper prescribing information with those products. The change would apply to products introduced into interstate commerce starting either two years after enactment or when final implementing regulations take effect, whichever comes first.

The bill was introduced in the Senate on August 4, 2026, by Sen. Jim Banks (R-IN) with Sen. Cory Booker as a cosponsor. It was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions, where it would need to be considered before any further action, such as a committee vote or floor consideration.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.